Aralez Bio Revenue and Competitors
Estimated Revenue & Valuation
- Aralez Bio's estimated annual revenue is currently $3.4M per year.
- Aralez Bio's estimated revenue per employee is $155,000
Employee Data
- Aralez Bio has 22 Employees.
- Aralez Bio grew their employee count by 22% last year.
Aralez Bio's People
Name | Title | Email/Phone |
---|---|---|
1 | Co-founder & CEO | Reveal Email/Phone |
2 | Co-founder & CTO | Reveal Email/Phone |
3 | Executive Assistant to the CEO & Operations Manager | Reveal Email/Phone |
4 | Chief Staff | Reveal Email/Phone |
5 | VP Finance (Fractional) | Reveal Email/Phone |
6 | Associate Quality Assurance Manager | Reveal Email/Phone |
7 | Process Chemist | Reveal Email/Phone |
8 | Lead Protein Engineer at Aralez Bio | Reveal Email/Phone |
9 | Chemist | Reveal Email/Phone |
10 | Research Associate | Reveal Email/Phone |
Aralez Bio Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is Aralez Bio?
We have invented a novel enzymatic method for synthesizing noncanonical amino acids (ncAAs) also called unusual or unnatural amino acids. Our proprietary approach enables over 100 ncAAs to be synthesized with perfect enantiopurity in just a single step, with water as the only byproduct. To learn more, visit us at www.aralezbio.com Aralez Bio is a proud member of Cyclotron Road.
keywords:N/AN/A
Total Funding
22
Number of Employees
$3.4M
Revenue (est)
22%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $3.7M | 22 | -8% | N/A |
#2 | $3.4M | 22 | -24% | N/A |
#3 | $3.4M | 22 | -4% | N/A |
#4 | $2.2M | 22 | 5% | N/A |
#5 | $3.9M | 22 | 16% | N/A |